Patent · US Active

Azaindole rock inhibitors

US12286433B1 · kind B1 · utility

0Cited by
2References
1Claims
0Family size

Assignee

Inventor

Key dates

Filing dateOct 14, 2024
Grant dateApr 29, 2025
Priority date
Expiry dateOct 14, 2044

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K47/38
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention provides rho-associated protein kinase (ROCK) inhibiting compounds for therapeutic applications as described further herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.